Myldrox (Meldonium Dihydrate)

Meldonium raises cellular carnitine levels, which enhances the transport of fatty acids into mitochondria for oxidation. This shift improves energy production in heart muscle cells, supports cardiac contractility, and reduces the buildup of harmful metabolites during periods of reduced blood flow.

The dosage of Myldrox is determined by the prescribing physician based on the individual patient's clinical condition, severity of disease, and response to therapy. Patients should follow the specific dosing instructions provided by their healthcare professional.

The safety of Meldonium in pregnancy and lactation has not been established. It should be used only if the potential benefit justifies any potential risk to the fetus or infant, and the decision should be made by a qualified healthcare provider.

To place an order, submit an enquiry on the Myldrox product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Unlike traditional nitrates or beta‑blockers, Meldonium acts as a metabolic modulator, targeting cellular energy pathways rather than directly influencing vascular tone or heart rate. This distinct mechanism can complement other therapies, but comparative effectiveness depends on individual patient factors and should be evaluated by a clinician.

Myldrox should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture and direct sunlight to maintain its stability and potency throughout its shelf life.

Myldrox is taken orally, usually with water. The exact timing relative to meals and other medications should follow the prescribing physician’s instructions to ensure optimal absorption and therapeutic effect.

Serious adverse events, though rare, can include significant hypotension, arrhythmias, myocardial infarction, severe allergic reactions such as anaphylaxis, and liver toxicity. Patients should be monitored for these signs and seek immediate medical attention if they occur.

Myldrox is contraindicated in patients with known hypersensitivity to Meldonium or any excipients in the formulation. Caution is advised for individuals with severe renal or hepatic impairment, uncontrolled hypertension, or those taking medications that may interact dangerously, such as certain anticoagulants.